Treatment of Pruritus
The treatment of pruritus must be tailored to the underlying cause, and the 2018 British Association of Dermatologists guidelines provide the most comprehensive, evidence-based algorithmic approach to management 1.
General Approach: Identify the Underlying Cause First
The key to effective pruritus management is determining whether you're dealing with:
- Pruritus on diseased/inflamed skin (treat the underlying dermatosis)
- Pruritus on non-diseased skin (investigate systemic causes)
- Pruritus with severe chronic scratch lesions (focus on breaking the itch-scratch cycle)
Cause-Specific Treatment Algorithms
Hepatic Pruritus (Cholestatic)
Follow this stepwise approach 1:
- First-line: Rifampicin (Strength of recommendation A - the highest quality evidence)
- Second-line: Cholestyramine
- Third-line: Sertraline
- Fourth-line: Naltrexone or nalmefene
- Fifth-line options:
- Dronabinol, phenobarbitone, propofol, or topical tacrolimus
- Novel agents targeting bile acid transport or autotaxin pathways
- BB-UVB or combined UVA/UVB phototherapy
- Transcutaneous electrical nerve stimulation
Critical caveat: Do NOT use gabapentin in hepatic pruritus 1.
Uraemic Pruritus (Chronic Kidney Disease)
Start with optimization before adding symptomatic treatments 1:
Foundation (must do first):
- Ensure adequate dialysis
- Normalize calcium-phosphate balance
- Control parathyroid hormone levels
- Correct anemia with erythropoietin
- Apply simple emollients for xerosis
Symptomatic treatments:
- BB-UVB phototherapy (Strength of recommendation A - most effective)
- Consider: capsaicin cream, topical calcipotriol, or oral gabapentin (all Strength D)
- Avoid sedative antihistamines long-term (may predispose to dementia, Strength B)
- Cetirizine is NOT effective in uraemic pruritus
- Alternative approaches: auricular acupressure or aromatherapy
- Definitive treatment: renal transplantation
Drug-Induced Pruritus
Opioid-induced:
- First choice: Naltrexone (Strength of recommendation B)
- Alternatives: methylnaltrexone, ondansetron, droperidol, mirtazapine, or gabapentin
Postoperative:
- Diclofenac 100 mg rectally
Chloroquine-induced:
- Prednisolone 10 mg, niacin 50 mg, or combination
- Alternative: dapsone
General principle: Trial cessation of suspected medications when risk-benefit analysis permits 1.
Lymphoma-Associated Pruritus
Multiple options with similar evidence levels 1:
- Cimetidine, carbamazepine, gabapentin, or mirtazapine (all Strength D)
- For incurable lymphoma: oral corticosteroids
- Phototherapy: BB-UVB for Hodgkin lymphoma; NB-UVB for non-Hodgkin lymphoma
Polycythaemia Vera
- Cytoreductive therapy, aspirin, interferon-α, SSRIs, PUVA, UVB phototherapy, cimetidine, or atenolol
- Phototherapy options: NB-UVB, BB-UVB, PUVA (note: relapse common after stopping)
Paraneoplastic Pruritus (Solid Cancers)
- Paroxetine, mirtazapine, granisetron, or aprepitant 1
Iron-Related Pruritus
- Iron deficiency: Iron replacement (Strength C)
- Iron overload: Venesection or desferrioxamine infusion
Neuropathic Pruritus
Refer to the relevant specialist for treatment - this requires specialized management 1.
Pruritus of Unknown Origin (GPUO)
When no cause is identified, follow this stepwise approach 1:
Step 1 - Basic therapy:
- Self-care advice and emollients (mandatory)
- Nonsedative antihistamines: fexofenadine 180 mg or loratadine 10 mg
- Mildly sedative option: cetirizine 10 mg
- Consider H1 + H2 combination (e.g., fexofenadine + cimetidine)
Topical options:
- Consider: Topical doxepin (limit to 8 days, 10% body surface area, 12 g daily max)
- May benefit from: Topical clobetasone butyrate or menthol (Strength D)
- Do NOT use: Crotamiton cream (Strength B), topical capsaicin, or calamine lotion
Step 2 - Systemic therapies: Consider paroxetine, fluvoxamine, mirtazapine, naltrexone, butorphanol, gabapentin, or pregabalin
Step 3 - Refer to secondary care if diagnostic doubt exists or primary management fails.
Psychogenic/Psychological Pruritus
Multimodal approach required 1:
- Psychosocial and behavioral interventions: education on trigger avoidance, lifestyle modifications, relaxation techniques, cognitive restructuring, habit reversal training
- Patient support groups
- Consider referral to social workers, liaison psychiatry, or psychologists
- NB-UVB phototherapy may benefit functional itch disorder
- Recent evidence supports SSRIs (particularly escitalopram), naltrexone, gabapentin, and NK-1R antagonists 2
Emerging Therapies
Novel agents showing promise include 3, 4, 5, 6:
- JAK inhibitors: Upadacitinib, abrocitinib, baricitinib (particularly effective for atopic dermatitis-associated pruritus)
- Biologics: Dupilumab, nemolizumab (anti-IL-31), tralokinumab
- κ-opioid receptor agonists: Difelikefalin (approved for chronic kidney disease-associated pruritus)
- NK-1 receptor antagonists: Serlopitant
- IBAT inhibitors for cholestatic pruritus
Critical Pitfalls to Avoid
- Never use gabapentin in hepatic pruritus - it's contraindicated 1
- Avoid long-term sedative antihistamines except in palliative care (dementia risk) 1
- Cetirizine is ineffective in uraemic pruritus - don't waste time with it 1
- Don't use crotamiton cream for GPUO (Strength B evidence against it) 1
- Always investigate for underlying causes before labeling as psychogenic - psychiatric disorders commonly coexist with physical causes 1
- Consider drug cessation when appropriate - many medications cause pruritus 1